20-HETE and F2-isoprostanes in the metabolic syndrome: the effect of weight reduction.
about
Obesity and physical frailty in older adults: a scoping review of lifestyle intervention trials20-HETE induces hyperglycemia through the cAMP/PKA-PhK-GP pathway.Adipocytokines in atherothrombosis: focus on platelets and vascular smooth muscle cells.Transcriptomic coordination in the human metabolic network reveals links between n-3 fat intake, adipose tissue gene expression and metabolic health20-Hydroxyeicosatetraenoic acid synthesis is increased in human neutrophils and platelets by angiotensin II and endothelin-1.Microparticles mediate hepatic ischemia-reperfusion injury and are the targets of Diannexin (ASP8597)HO-1 Upregulation Attenuates Adipocyte Dysfunction, Obesity, and Isoprostane Levels in Mice Fed High Fructose Diets.Effect of modest caloric restriction on oxidative stress in women, a randomized trial.20-HETE Signals Through G-Protein-Coupled Receptor GPR75 (Gq) to Affect Vascular Function and Trigger Hypertension.Oxidative stress measured by urine F2-isoprostane level is associated with prostate cancerPlasma phospholipids, non-esterified plasma polyunsaturated fatty acids and oxylipids are associated with BMI.n-3 Fatty Acid Supplementation and Leukocyte Telomere Length in Patients with Chronic Kidney DiseaseCyclooxygenase-2 dependent metabolism of 20-HETE increases adiposity and adipocyte enlargement in mesenchymal stem cell-derived adipocytes.Effects of insulin resistance and testosterone on the participation of cyclooxygenase isoforms in vascular reactivity.Classifying oxidative stress by F2-isoprostane levels across human diseases: A meta-analysis.Alterations of specific lipid groups in serum of obese humans: a review.Association of altered hemorheology with oxidative stress and inflammation in metabolic syndrome.Dietary Weight Loss, Exercise, and Oxidative Stress in Postmenopausal Women: A Randomized Controlled Trial.Measurement of urinary F(2)-isoprostanes by gas chromatography-mass spectrometry is confounded by interfering substances.Total antioxidant capacity and oxidative stress after a 10-week dietary intervention program in obese children.A Randomized Trial of Effects of Alcohol on Cytochrome P450 Eicosanoids, Mediators of Inflammation Resolution, and Blood Pressure in Men.The Physiopathology of Cardiorenal Syndrome: A Review of the Potential Contributions of Inflammation.Elevated 20-HETE in metabolic syndrome regulates arterial stiffness and systolic hypertension via MMP12 activation.Cytochrome P450 metabolites of arachidonic acid are elevated in stroke patients compared with healthy controls
P2860
Q33622142-B263ABAF-B262-4A18-9286-951CB370D1B7Q33636288-CAB3060B-67BE-4800-BFAB-7A6F39ED1AC7Q34002877-F422454F-0051-4D46-BE3A-30A0C54628C6Q34071331-166E5B70-0953-46EC-88FC-D7C948776B2CQ34159332-34779437-1154-44E0-9E60-E5E64EFA59ACQ34182691-80F54371-929E-4FE1-96D9-4F295BD4CF4AQ34247114-271C3D5E-2FB9-4981-9E8A-E4CEA5EB76A2Q34447871-818A8218-C93B-4EC6-837E-A737AC19C73EQ34553783-13CB2AA6-C312-4AE1-A7A3-E1E872747412Q34977627-940E1B9C-F44C-4B0C-893D-89550DED0CE0Q35181326-EFFFB61D-ED93-4A27-9373-07CFB02EF316Q36732191-70522853-84FC-4010-AEC8-6E7233D39C56Q36744134-197E7B43-0F49-423A-BB4C-A2671BF2F09BQ36890451-2CA49364-AC1D-4100-8FA9-71222CEC5B68Q37741459-2AFDC619-0C32-4AA7-855A-D315A0AEE21DQ39023727-0975BF81-F7D0-4B37-B20F-2EB94C82178EQ41705514-27549D8B-BE07-4803-A178-33FB9EA80C3DQ42759081-27E3B5EC-21B6-4A30-9602-61F06D02B796Q43237790-DE8BE339-5561-4A34-9797-77DE384C2C63Q46714535-D8B6A51E-7033-499F-B907-1C883BA27544Q47947231-EF67FAAC-1EB0-4BAF-A0F4-E410591C161DQ48172048-1140CAD2-44DB-4F1C-987E-2BDEFBE97B87Q50081720-89CFC174-23B1-4A61-843A-50308B907FAFQ57313058-F1836432-E93B-452C-8E2F-4C233E5F51F8
P2860
20-HETE and F2-isoprostanes in the metabolic syndrome: the effect of weight reduction.
description
2008 nî lūn-bûn
@nan
2008 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
20-HETE and F2-isoprostanes in the metabolic syndrome: the effect of weight reduction.
@ast
20-HETE and F2-isoprostanes in the metabolic syndrome: the effect of weight reduction.
@en
20-HETE and F2-isoprostanes in the metabolic syndrome: the effect of weight reduction.
@nl
type
label
20-HETE and F2-isoprostanes in the metabolic syndrome: the effect of weight reduction.
@ast
20-HETE and F2-isoprostanes in the metabolic syndrome: the effect of weight reduction.
@en
20-HETE and F2-isoprostanes in the metabolic syndrome: the effect of weight reduction.
@nl
prefLabel
20-HETE and F2-isoprostanes in the metabolic syndrome: the effect of weight reduction.
@ast
20-HETE and F2-isoprostanes in the metabolic syndrome: the effect of weight reduction.
@en
20-HETE and F2-isoprostanes in the metabolic syndrome: the effect of weight reduction.
@nl
P2093
P1476
20-HETE and F2-isoprostanes in the metabolic syndrome: the effect of weight reduction.
@en
P2093
Anne E Barden
I-Jung Tsai
Ian B Puddey
Lawrence J Beilin
Trevor A Mori
P304
P356
10.1016/J.FREERADBIOMED.2008.10.028
P577
2008-11-01T00:00:00Z